Bortezomib label revised for patients with hepatic impairmen
Publicado: Lun Feb 01, 2010 9:47 am
"Bortezomib label revised for patients with hepatic impairment"
Fuente:
HenOnctoday:
Posted January 26, 2010
"The FDA and Takeda Oncology have issued a notice to health care professionals about changes made to the prescribing information for bortezomib".
http://www.hemonctoday.com/article.aspx?rid=60389
Fuente:
HenOnctoday:
Posted January 26, 2010
"The FDA and Takeda Oncology have issued a notice to health care professionals about changes made to the prescribing information for bortezomib".
http://www.hemonctoday.com/article.aspx?rid=60389